Entering edit mode
Dear BioC list and Biocore Data Team,
we are using various Agilent arrays and the recent paper by Gertz et
al.
( http://www.biomedcentral.com/1471-2164/10/566 ) made me feel a
little bit uneasy about the annotation provided by that vendor.
As far as I understand, BioC annotation, e.g. in package hgug4112a.db,
is using EntrezGene IDs as keys to retrieve public annotation for a
given
EntrezGene entry -- but where does the mapping from Agilent's Oligo ID
to EntrezGene come from?
I have tried to find the answer in the package's reference manual and
help
pages but would prefer to be absolutely sure in this case...
Thanks in advance,
- axel
P.S., I do not yet have much experience with sequence analysis in BioC
and would also be grateful for pointers to packages that could help me
verify oligo mappings myself.
Axel Klenk
Research Informatician
Actelion Pharmaceuticals Ltd / Gewerbestrasse 16 / CH-4123 Allschwil /
Switzerland
The information of this email and in any file transmitted with it is
strictly confidential and may be legally privileged.
It is intended solely for the addressee. If you are not the intended
recipient, any copying, distribution or any other use of this email is
prohibited and may be unlawful. In such case, you should please notify
the sender immediately and destroy this email.
The content of this email is not legally binding unless confirmed by
letter.
Any views expressed in this message are those of the individual
sender, except where the message states otherwise and the sender is
authorised to state them to be the views of the sender's company. For
further information about Actelion please see our website at
http://www.actelion.com